Kineta, Inc.
KADelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001445283
Kineta, Inc. was delisted in 2024; its insiders filed their last Form 4 on Jul 2, 2025; 26 institutions reported holding it in 13F filings for Q2 2024, worth $388.5K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Kineta, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Kineta, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Arkowitz David | Director | 0 | Jul 2, 2025 | 0 |
| Drapkin Kimberlee C | Director | 0 | Jul 2, 2025 | 0 |
| Philips Craig W. | President and Secretary | 0Indirect | Jul 2, 2025 | 0 |
| Foote Marion R | Director | 0 | Jul 2, 2025 | 0 |
| Peters Richard | Director | 0 | Jul 2, 2025 | 0 |
| Bartoszek Raymond J. | Director | 0Indirect | Jul 2, 2025 | 0 |
| Baker Keith | Chief Financial Officer | 0 | Jul 2, 2025 | 0 |
| Guillaudeux Thierry | Chief Scientific Officer | 0 | Jul 2, 2025 | 0 |
| Iadonato Shawn | Director | 0Indirect | Jul 2, 2025 | 0 |
| Dylla Scott J. | Director | 0 | Jul 2, 2025 | 0 |
| Kenny Pauline | General Counsel & Secretary | 18,448 | Sep 21, 2023 | 0 |
| Smith Devin Whittemore | SVP and General Counsel | 13,961 | Dec 6, 2022 | 0 |
| Epstein Marie | Principal Accounting Officer | 8,883 | Dec 6, 2022 | 0 |
| Wyzga Michael D | See Remarks | 13,997 | Dec 6, 2022 | 0 |
| Mohsen Paulash | Chief Business Officer | 59,135 | Feb 7, 2022 | 0 |
| Verma Ajay | EVP, Head of R&D | 30,000 | Dec 3, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2023 (view filing) | Dec 4-6 | 2 days | Bartoszek Raymond J.Director | PPurchase | +2.25K | $4.42 | +$9.96K | +15.0%17.2K after | 3 lots |
| Nov 30, 2023 (view filing) | Nov 28 | 2 days | Philips Craig W.President | PPurchase | +3.00K | $3.27 | +$9.81K | +5.2%60.8K after | |
| Nov 30, 2023 (view filing) | Nov 28-29 | 2 days | Iadonato ShawnChief Executive Officer | PPurchase | +5.00K | $3.48 | +$17.4K | +0.7%675.2K after | 2 lots |
| Sep 21, 2023 (view filing) | Sep 20-21 | 1 day | Philips Craig W.President | PPurchase | +3.50K | $2.42 | +$8.48K | +6.4%57.8K after | 2 lots |
| Sep 21, 2023 (view filing) | Sep 20 | 1 day | Kenny PaulineGeneral Counsel & Secretary | PPurchase | +1.50K | $2.58 | +$3.87K | +8.9%18.4K after | |
| Sep 21, 2023 (view filing) | Sep 20 | 1 day | Iadonato ShawnChief Executive Officer | PPurchase | +10.0K | $2.50 | +$25.0K | +1.5%670.2K after | |
| Sep 21, 2023 (view filing) | Sep 19 | 2 days | Bartoszek Raymond J.Director | PPurchase | +2.00K | $2.37 | +$4.74K | +15.4%15.0K after | |
| Sep 19, 2023 (view filing) | Sep 18 | 1 day | Baker KeithChief Financial Officer | PPurchase | +5.00K | $2.13 | +$10.7K | +42.1%16.9K after | |
| Sep 19, 2023 (view filing) | Sep 15-18 | 4 days | Bartoszek Raymond J.Director | PPurchase | +3.00K | $2.10 | +$6.29K | +30.1%13.0K after | 2 lots |
| Sep 15, 2023 (view filing) | Sep 14 | 1 day | Guillaudeux ThierryChief Scientific Officer | PPurchase | +10.0K | $2.00 | +$20.0K | +85.5%21.7K after | |
| Jun 16, 2023 (view filing) | Jun 16 | Same day | Baker KeithChief Financial Officer | PPurchase | +5.00K | $2.92 | +$14.6K | +72.7%11.9K after | |
| Mar 21, 2023 (view filing) | Mar 17-20 | 4 days | Philips Craig W.President | SSale | −2.10K | $4.26 | −$8.96K | −3.0%67.0K after | 4 lots |
| Mar 21, 2023 (view filing) | Mar 17-20 | 4 days | Kenny PaulineGeneral Counsel & Secretary | SSale | −1.31K | $4.26 | −$5.59K | −6.9%17.8K after | 3 lots |
| Mar 21, 2023 (view filing) | Mar 17-20 | 4 days | Iadonato ShawnChief Executive Officer | SSale | −2.70K | $4.25 | −$11.5K | −0.4%666.3K after | 3 lots |
| Jan 4, 2023 (view filing) | Dec 30, 2022 | 5 days | Bartoszek Raymond J.Director | PPurchase | +5.00K | $6.23 | +$31.1K | +100.9%9.96K after | |
| Jan 4, 2023 (view filing) | Dec 30, 2022 | 5 days | Bartoszek Raymond J.Director | PPurchase | +2.00K | $6.23 | +$12.5K | New position1.00K after | 2 lots |
| Dec 6, 2022 (view filing) | Dec 2 | 4 days | Peters RichardPresident and CEO | SSale | −10.9K | $1.69 | −$18.4K | −10.8%90.0K after | |
| Dec 6, 2022 (view filing) | Dec 2 | 4 days | Wyzga Michael DSee Remarks | SSale | −3.12K | $1.69 | −$5.27K | −18.2%14.0K after | |
| Dec 6, 2022 (view filing) | Dec 2 | 4 days | Epstein MariePrincipal Accounting Officer | SSale | −1.98K | $1.69 | −$3.34K | −18.2%8.88K after | |
| Dec 6, 2022 (view filing) | Dec 2 | 4 days | Smith Devin WhittemoreSVP and General Counsel | SSale | −3.12K | $1.69 | −$5.27K | −18.2%14.0K after | |
| Jul 6, 2022 (view filing) | Jul 5 | 1 day | Peters RichardPresident and CEO | SSale | −4.58K | $1.85 | −$8.48K | −4.3%100.9K after | |
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Epstein MariePrincipal Accounting Officer | SSale | −1.81K | $1.19 | −$2.15K | −14.3%10.9K after | |
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Smith Devin WhittemoreSVP and General Counsel | SSale | −2.92K | $1.19 | −$3.48K | −14.6%17.1K after | |
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Wyzga Michael DSee Remarks | SSale | −2.89K | $1.19 | −$3.44K | −14.4%17.1K after | |
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Peters RichardPresident and CEO | SSale | −10.2K | $1.19 | −$12.1K | −8.8%105.5K after | |
| Mar 30, 2022 (view filing) | Mar 28 | 2 days | Peters RichardPresident and CEO | SSale | −10.7K | $1.85 | −$19.8K | −8.5%115.7K after | |
| Feb 7, 2022 (view filing) | Feb 3 | 4 days | Mohsen PaulashChief Business Officer | SSale | −1.96K | $1.83 | −$3.58K | −3.2%59.1K after |